Purchases and Sales Made in Q4 2022 in Cyteir Therapeutics, Inc. (CYT)
This table provides information about the institutional ownership of Cyteir Therapeutics, Inc. (CYT) during Q4 2022. The information is specifically focused on institutions that hold shares of Cyteir Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Newtyn Management, LLC
New York, NY |
BUY
|
- |
366K+ 55.94% |
$432K - $644K
|
1.02M
$3.07M
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
60.1K+ 50.43% |
$71K - $106K
|
179K
$540K
|
|
Feb 14, 2023
Q4 2022
|
Ergoteles LLC
New York, NY |
BUY
|
- |
30.1KNew |
$35.6K - $53.1K
|
30.1K
$90.7K
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
21KNew |
$24.8K - $37K
|
21K
$63.3K
|
|
Jan 30, 2023
Q4 2022
|
International Assets Investment Management, LLC
Orlando, FL |
BUY
|
- |
14.4KNew |
$17K - $25.3K
|
14.4K
$43.3K
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
3.81K+ 18.14% |
$4.5K - $6.71K
|
24.8K
$74.7K
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
3.5K+ 3.08% |
$4.13K - $6.17K
|
117K
$353K
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
1.73K+ 13.15% |
$2.04K - $3.05K
|
14.9K
$44.9K
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
291+ 0.05% |
$343 - $512
|
585K
$1.76M
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 3.19% |
$3.54 - $5.28
|
97
$292
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
3New |
$3.54 - $5.28
|
3
$9.03
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-423- 63.23% |
$499 - $744
|
246
$740
|
|
Feb 14, 2023
Q4 2022
|
Rbf Capital, LLC
San Francisco, CA |
SELL
|
- |
-1.1K- 0.72% |
$1.3K - $1.94K
|
151K
$455K
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.54K- 75.59% |
$1.81K - $2.7K
|
496
$1.49K
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-2.3K- 8.13% |
$2.71K - $4.05K
|
26K
$78.3K
|
|
Feb 02, 2023
Q4 2022
|
Oup Management Co., LLC
|
SELL
|
- |
-10K- 0.4% |
$11.8K - $17.6K
|
2.46M
$7.4M
|
|
Feb 14, 2023
Q4 2022
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-10.4K- 0.58% |
$12.3K - $18.3K
|
1.8M
$5.41M
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-37.6K- 14.1% |
$44.4K - $66.2K
|
229K
$690K
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-39.1K- 56.34% |
$46.1K - $68.7K
|
30.3K
$91.1K
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-118K- 59.71% |
$139K - $207K
|
79.3K
$239K
|
|
Feb 14, 2023
Q4 2022
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-152K- 5.73% |
$179K - $267K
|
2.49M
$7.5M
|
|
Feb 14, 2023
Q4 2022
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-157K- 25.46% |
$185K - $276K
|
460K
$1.38M
|